Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$985K Buy
27,552
+6,972
+34% +$250K 0.02% 390
2019
Q2
$720K Sell
20,580
-2,660
-11% -$92.5K 0.02% 485
2019
Q1
$798K Buy
23,240
+2,660
+13% +$97.6K 0.02% 434
2018
Q4
$658K Hold
20,580
0.02% 447
2018
Q3
$942K Buy
20,580
+4,704
+30% +$237K 0.02% 393
2018
Q2
$839K Hold
15,876
0.02% 384
2018
Q1
$793K Buy
15,876
+112
+0.7% +$5.64K 0.02% 392
2017
Q4
$756K Buy
15,764
+2,436
+18% +$115K 0.02% 421
2017
Q3
$614K Buy
13,328
+1,064
+9% +$46.1K 0.02% 442
2017
Q2
$543K Buy
12,264
+4,032
+49% +$169K 0.02% 474
2017
Q1
$338K Buy
8,232
+1,008
+14% +$42K 0.01% 520
2016
Q4
$297K Buy
+7,224
New +$266K 0.01% 516

Other funds holding SNV

Elkfork Partners's SNV Position: Q3 2019 in Review

Elkfork Partners increased its Synovus (SNV) stake by 34% in Q3 2019, buying an estimated $250K and bringing the position to 27,552 shares worth $985K. The position accounts for 0.02% of the portfolio, ranked #390.

Elkfork Partners first reported a position in SNV in Q4 2016 and has held it in 12 quarters since. 389 funds tracked by Wall St. Rank hold SNV as of Q3 2019.

  • Elkfork Partners held 27,552 shares of Synovus worth $985K as of Q3 2019.
  • Elkfork Partners bought 6,972 Synovus shares in Q3 2019, an estimated $250K.
  • Synovus made up 0.02% of Elkfork Partners's portfolio in Q3 2019, its #390 holding.
  • Elkfork Partners first reported a position in Synovus in Q4 2016 and has held it in 12 quarters since.
  • 389 funds tracked by Wall St. Rank held Synovus as of Q3 2019.

Based on Elkfork Partners's 13F filing for Q3 2019, filed 14 Nov 2019.